Malta Warns Residents: Rosabella Moringa Capsules Recalled Over Salmonella Risk

A Critical Health Alert for Malta's Online Shoppers

The Malta Food Safety and Security Authority has issued a warning to residents about contaminated Rosabella-brand Moringa 100% Pure Capsules that may have been purchased through international online retailers. A drug-resistant Salmonella strain detected in the United States has prompted this recall, with at least seven confirmed cases documented across American states, including three requiring hospitalization.

Why This Matters

• Antibiotic resistance complicates medical response: The bacterial strain doesn't respond to standard antibiotics, forcing doctors to identify susceptibility through laboratory testing before treatment begins, delaying recovery.

• Specific lot codes in circulation through 2027: Affected batches won't expire until late 2027, meaning contaminated capsules may remain in medicine cabinets across Malta indefinitely.

• Purchased through popular international platforms: The product was distributed internationally through channels frequently used for supplement purchases by Maltese consumers.

The contamination originates from Ambrosia Brands LLC, a Wyoming-based manufacturer that initiated a voluntary recall on February 13, 2026, after discovering bacterial contamination in specific production batches. The outbreak investigation, jointly coordinated by the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), involves illnesses dating back to November 2025. As of mid-March 2026, the outbreak remains active with seven confirmed infections across seven American states and three requiring hospital admission.

Unlike typical food poisoning that resolves independently, Salmonella Newport carries extensive antibiotic resistance. This classification means patients cannot simply receive standard fluoroquinolone antibiotics that typically clear Salmonella infections within days. Instead, doctors must conduct bacterial culture tests and susceptibility panels—a process requiring 48 to 72 hours—before identifying which antibiotic combination might work. During this diagnostic window, the infection progresses unchecked.

Identifying the Affected Product

The recalled capsules arrive in white plastic bottles displaying a green Rosabella label, containing 60 capsules per container. The manufacturer distributed these internationally, making them purchasable through channels readily accessed by residents ordering dietary supplements online.

The contamination affects specific production runs. To determine whether your bottle poses risk, locate the alphanumeric code on the bottom surface, printed directly above the "best before" date. Extract the middle seven digits—this is your lot code. Cross-reference against these affected ranges:

5020591 through 5020596 (expires 03/2027); 5030246 through 5030251 (04/2027); 5040270 through 5040279 (05/2027); 5050053 through 5050056 (06/2027); 5060069 through 5060080 (07/2027); 5080084 through 5080086 (09/2027); 5090107 through 5090118 (10/2027); plus isolated lots 5100039 and 5100048 (11/2027).

Given expiration dates extending into late 2027, supplement bottles purchased during 2025 and early 2026 from international retailers remain active hazards.

Understanding Salmonella Risk in Your Body

Salmonella infection onset typically occurs 12 to 36 hours after exposure, though symptoms can appear within 6 hours or take up to 72 hours. The primary manifestation is acute diarrhea—occasionally with blood in stool. Accompanying symptoms commonly include fever, severe abdominal cramping, and headache. Most healthy adults experience illness lasting 4 to 7 days, recovering through natural resolution and hydration management.

However, this outbreak involves a drug-resistant strain, fundamentally altering the clinical picture. Standard treatment protocols may be less effective. More critically, certain populations face substantially elevated risk of severe complications: elderly residents, infants, individuals undergoing chemotherapy, those with HIV, and anyone taking immunosuppressive medications for autoimmune diseases. For these groups, Salmonella infection carries risk of arterial infections, heart valve inflammation, or chronic reactive arthritis—conditions requiring prolonged hospitalization and long-term medical management.

In rare cases, the bacteria escape the digestive tract entirely and enter the bloodstream, a condition called bacteremia. This progression was documented in three of the seven current outbreak cases, explaining their hospitalization requirement despite Salmonella typically being self-limiting.

Immediate Action Steps for Residents

Stop using Rosabella Moringa 100% Pure Capsules today. Verify your bottle's lot code against the affected ranges listed above. If your product matches, either dispose of the capsules completely or return them to the retailer where purchased.

Decontaminate any surface, utensil, or storage container that contacted the capsules using hot soapy water or a dishwasher cycle. This eliminates residual bacterial contamination that could transfer to other foods or hands.

Do not share remaining capsules with family members or friends. Do not attempt to use the product in smaller quantities. This is not a cautionary suggestion; it reflects active health risk.

What to Do If You've Already Consumed the Product

If you took these capsules within the past 72 hours and develop diarrhea, fever, abdominal pain, or headache, contact your healthcare provider immediately. Inform them specifically that you consumed a product contaminated with drug-resistant Salmonella Newport—this diagnostic information directly guides treatment decisions.

Avoid over-the-counter antidiarrheal medications without medical consultation. While they temporarily reduce symptoms, they can paradoxically prolong Salmonella infections by trapping bacteria longer in your digestive system.

Most healthy adults recover through supportive hydration and electrolyte replacement. Severe cases or those affecting vulnerable populations require hospital admission for intravenous fluid therapy and evidence-based antibiotic selection based on bacterial susceptibility testing.

What's Being Done Now

The Malta Food Safety and Security Authority emphasizes that suspected illnesses should be reported to healthcare providers or public health authorities. Health departments in the United Arab Emirates and Singapore have issued parallel warnings, reflecting the product's global distribution network.

International regulatory coordination remains active. The FDA and CDC continue outbreak investigation, indicating this remains an unresolved public health event rather than a historical incident. For Maltese residents with specific questions about purchased supplements, contacting the Malta Food Safety and Security Authority through official channels provides verification before consumption, particularly valuable if you cannot locate your original purchase receipt or remember the specific retailer.

This incident underscores why dietary supplements warrant regulatory scrutiny distinct from pharmaceutical medications. Supplements enter distribution with minimal mandatory pre-market safety testing or contamination screening. When manufacturers source ingredients without stringent quality oversight, contamination can reach consumers without warning or detection mechanisms.